Methods and reagents for improved cell-based assays

Details Methods and reagents for improved cell-based assays Methods and reagents for improved cell-based assays

2006-04-11

2006-04-11

Prats, Francisco C. (Department: 1651)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

C435S006120, C435S011000, C435S013000, C435S014000, C435S018000, C435S019000, C435S020000, C435S021000, C435S023000, C435S024000, C435S219000, C435S226000, C436S063000, C436S064000, C436S164000, C436S172000

Reexamination Certificate

active

07026111

ABSTRACT:
The ability to efficiently determine the state of enzyme expression in cells has long been desired as material to the diagnosis of disease. This invention relates to cytoenzymology, and more particularly to improved reagents for use in cell-based assays, especially those using fluorogenic substrates.

REFERENCES:
patent: 4557862 (1985-12-01), Mangel et al.
patent: 4640893 (1987-02-01), Mangel et al.
patent: 4940659 (1990-07-01), Warrington et al.
patent: 5070012 (1991-12-01), Nolan et al.
patent: 5238108 (1993-08-01), Velezis et al.
patent: 5310687 (1994-05-01), Bard et al.
patent: 5698411 (1997-12-01), Lucas et al.
patent: 5759781 (1998-06-01), Ward et al.
patent: 5976822 (1999-11-01), Landrum et al.
patent: 6174673 (2001-01-01), Short et al.
patent: 6248904 (2001-06-01), Zhang et al.
patent: 6281021 (2001-08-01), Egger et al.
Los et al , Nature 375: 81-83, 1995.
Wansink et al . J. Cell. Biol. 122(2):283-293, 1993.
Alberts, B. et al., Molecular Biology of the Cell, 2nd Edition. Garland Publishing, Inc. New York, p. 704.
Alnemri, et al., “Human ICE/CED-3 protease nomenclature,”Cell, 1996 Oct. 18;87(2):171.
Ashmum RA and Look AT. 1990, “Metalloprotease Activity of CD13/Aminopeptidase N on the Surface of Human Myeloid Cells,”Blood75: 462-469.
Bass, D.A. et al. “Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.”J. Immunol. 130: 1910-1917.
Bode, W. et al., 1989, “Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity and mechanism-based inhibitors,”Biochem. 28: 1951-1963.
Coates, P.M. et al., 1975, “A preliminary genetic interpretation of the esterase isozymes of human tissues,”Ann. Hum. Genet. Lond. 39: 1-20.
Crockard, A. et al., 1982, “Cytochemistry of acid hydrolases in chronic B-and T-cell leukemias,”Am. J. Clin. Pathol. 78:437-444.
Darzynkiewicz, Z. et al. “Flow cytometry in analysis of cell cycle and apoptosis,”Semin Hematol. 2001 (Apr.,38(2):179-93.
Duque, R. E., “Flow Cytometric Analysis of Lymphomas and Acute Leukemias”,Annals of the New York Academy of Sciences, Clinical Flow Cytometry, 677, pp. 309-325 (Mar. 20, 1993).
Ferrer-Lopez, P. et al., “Heparin Inhibits Neutrophil-Induced Platelet Activation Via Cathepsin”,J. Lab Clin. Med.119(3), 231-239 (1992).
Fleischer, B., 1994, “CD26: a surface protease involved in T-cell activation,”Immunol. Today. 15: 180-184.
Gartner, T.K. et al., 1985, “The tetrapeptide analogue of the alpha chain and decapeptide analogue of the gamma chain of fibrinogen bind to different sites on the platelet fibrinogen receptor,”Blood. 66 Suppl 1: 305a.
Hoffmann, T. et al. 1993, “Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences,”FEBS Letters. 336: 61-64.
Hohn, P.A. et al., 1989, “Genomic organization and chromosomal localization of the human cathepsin G gene,”J. Biol. Chem. 264: 13412-13419.
Jongkind, J.F. et al., 1986, “Detection of acid-b -galactosidase activity in viable human fibroblasts by flow cytometry,”Cytometry7:463-466.
Kankaanranta, H. et al., 1994, “Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates,”Naunyn-Schmiedeberg's Arch Pharmacol. 350:685-691.
Kohen, E. et al., 1993, “An in situ study of beta-glucosidase activity in normal and gaucher fibroblasts with fluorogenic probes,”Cell Biochem. and Function. 11:167-177.
Kojima, K. et al., 1979, “A new and highly sensitive fluorescence assay for collagenase-like peptidase activity,”Anal. Biochem. 100: 43-50.
Leytus, S.P. et al., “New class of sensitive and selective fluorogenic substrates for serine proteases,”Biochem. J. 215:253-260 (1983).
Li, C.Y. et al., 1970, “Acid phosphatase isoenzyme in human leukocytes in normal and pathologic conditions,”J. Histochem. Cytochem. 18:473-481.
Look, A.T. et al. 1989, “Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N,”J. Clin. Invest. 83: 1299-1307.
McDonald, J.A. et al., 1980, “Degradation of fibronectin by human leukocyte elastase,”J. Biol. Chem. 255: 8848-8858.
Mentlein, R. et al., H. R., “Influence of Pregnancy on Dipeptidyl Peptidase IV Activity (CD26 Leukocyte Differentiation Antigen) of Circulating Lymphocytes”,Eur. J. Clin. Chem. Clin. Biochem., 29, 477-480 (1991).
Mononen, et al., “Enzymatic diagnosis of aspartylglycosaminuria by fluorometric assay of glycosylasparaginase in serum, plasma, or lymphocytes,”Clin. Chem. 1994 Mar.; 40(3):385-8.
Park, R.D. et al., “Hypertonic sucrose inhibition of endocytic transport suggests multiple early endocytic compartments,”J. Cell Physiol. 1988 Jun.;135(3):443-450).
Rechsteiner, M. “Osmotic lysis of pinosomes,” Methods Enzymol 1987;149:42-48; Okada, C.Y. et al., “Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles,”Cell1982 May;29(1):33-41.
Riss, T.L. “Apoptosis as a biomarker in chemoprevention trials,”Urology. 2001 Apr.;57(4 suppl 1):141-2.
Rothe et al., “Flow cytometric analysis of protease activities in vital cells,”Biol. Chem. Hoppe Seyler. Jul. 1992; 373(7): 547-54.
Rotman, B. et al., 1963, “Fluorogenic substrates for b-D-galactosidases and phosphatases derived from fluorescein (3,6-dihydroxyfluoran) and its monomethyl ether,”Proc. Nat. Acad. Sci. USA 50:1-6.
Royer, G. et al., “Immobilized Derivatives of Leucine Aminopeptidase and Aminopeptidase M,”J. Biol. Chem. 248(5), 1807-1812 (1973).
Ruiz, P. et al., 1996, “Cytofluorographic evidence thatthymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny and apoptotic status,”Cytometry. 23: 322-329.
Sanderink, G.J. et al., 1988, Human Aminopeptidases: A Review of the Literature.J. Clin. Chem. Clin. Biochem. 26: 795-807.
Saraste, A. et al. “Morphologic and biochemical hallmarks of apoptosis,”Cardiovasc Res. 2000 Feb.;45(3):528-37.
Saraste, A. et al. “Morphologic criteria and detection of apoptosis,”Herz. May 1999;24(3):189-95.
Schon, E. et al., “The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro,”Eur. J. Immunol. Dec. 1987;17(12):1821-6.
Stein, R.L. et al. 1987, “Catalysis by human leukocyte elastase: Mechanistic insights into specificity requirements,”Biochem. 26:1301-1305.
Stein, R.L. et al. 1987, “Catalysis by human leukocyte elastase: Proton inventory as a mechanistic probe,”Biochem. 26:1305-1314.
Tanaka, T. et al., 1993, “The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity,”Proc. Natl. Acad. Sci. USA. 90: 4586-4590.
Thiele, D.L. et al., 1990, “Mechanism of L-leucyl-L-leucine methyl ester-mediated killing of cytotoxic lymphocytes: Dependence on a lysosomal thiol protease, dipeptidyl peptidase I, that is enriched in these cells,”Proc. Natl. Acad. Sci. USA. 87:83-87.
Valet et al, “White cell and thrombocyte disorders. Standardized, self-learning flow cytometric list mode data classification with the CLASSIF1 program system,”Ann. NY Acad. Sci. Mar. 20, 1993;677-233-51.
Watson, J., “Enzyme Kinetic Studies in Cell Population Using Fluorogenic Substrates and Flow Cytometric Techniques,”Cytometry, 1(2), p. 143 (1980).
Weiss. S.J. 1989, “Tissue destruction by neutrophils,”N. Eng. J. Med. 320: 365-376.
Whitlock, C.A., et al., 1987. “Bone marrow stromal cell lines with lymphopoietic activity express high levels of a p

Affiliated with

Also associated with

Rating

Methods and reagents for improved cell-based assays does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and reagents for improved cell-based assays, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and reagents for improved cell-based assays will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3620928